You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR LEVALBUTEROL TARTRATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for LEVALBUTEROL TARTRATE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00268723 ↗ Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB Completed Sunovion Phase 3 2005-12-01 To determine if administration of levalbuterol tartrate HFA MDI in subjects with EIB will be effective in the prevention of EIB and be safe and well-tolerated.
NCT00583947 ↗ A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects Completed Sunovion Phase 2 2008-01-01 To determine the safety and tolerability of Arformoterol Tartrate in children with asthma
NCT00583986 ↗ Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD Completed Sunovion Phase 3 2005-09-01 This is a study to investigate the reliability, ruggedness and safety of the top mounted actuation indicator (TMAI) when used with Levalbuterol HFA MDI.
NCT00809757 ↗ A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma Completed Sunovion Phase 3 2008-12-01 A Safety, Efficacy, and Tolerability Study of Daily Dosing with Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to <48 Months with Asthma.
NCT02150499 ↗ A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Terminated Sunovion Phase 3 2014-07-01 This is a study of levalbuterol tartrate HFA inhalation aerosol MDI in pediatric subjects birth to ≤ 48 months of age who go to the Emergency Department (ED) or their physician's office with an acute bronchospasm. Subjects presenting to the ED or physician's office with an acute bronchospasm must have a history of reactive airways disease, based on subjects' parent/guardian report.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for LEVALBUTEROL TARTRATE

Condition Name

Condition Name for LEVALBUTEROL TARTRATE
Intervention Trials
Asthma 4
Exercise-induced Bronchospasm 1
Chronic Obstructive Pulmonary Disease 1
COPD 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for LEVALBUTEROL TARTRATE
Intervention Trials
Asthma 4
Pulmonary Disease, Chronic Obstructive 1
Lung Diseases, Obstructive 1
Lung Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for LEVALBUTEROL TARTRATE

Trials by Country

Trials by Country for LEVALBUTEROL TARTRATE
Location Trials
United States 56
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for LEVALBUTEROL TARTRATE
Location Trials
Virginia 5
Texas 4
South Carolina 4
Tennessee 3
Florida 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for LEVALBUTEROL TARTRATE

Clinical Trial Phase

Clinical Trial Phase for LEVALBUTEROL TARTRATE
Clinical Trial Phase Trials
Phase 3 4
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for LEVALBUTEROL TARTRATE
Clinical Trial Phase Trials
Completed 4
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for LEVALBUTEROL TARTRATE

Sponsor Name

Sponsor Name for LEVALBUTEROL TARTRATE
Sponsor Trials
Sunovion 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for LEVALBUTEROL TARTRATE
Sponsor Trials
Industry 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.